跳转至内容
Merck
CN

479306

顺二氯化二胺（II）

≥99.9% trace metals basis

别名:

顺铂, 顺-二氯二氨基铂(II), 顺式-二胺二氯铂, 顺氯氨铂

登录 查看组织和合同定价。

选择尺寸

关于此项目

线性分子式:
Pt(NH3)2Cl2
化学文摘社编号:
15663-27-1
分子量:
300.05
NACRES:
NA.22
PubChem Substance ID:
24871609
UNSPSC Code:
12161600
EC Number:
239-733-8
MDL number:
MFCD00011623

主要文件

查看所有文档
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

顺二氯化二胺（II）, ≥99.9% trace metals basis

InChI key

LXZZYRPGZAFOLE-UHFFFAOYSA-L

InChI

1S/2ClH.2H3N.Pt/h2*1H;2*1H3;/q;;;;+2/p-2

SMILES string

N.N.Cl[Pt]Cl

assay

≥99.9% trace metals basis

reaction suitability

core: platinum
reagent type: catalyst

mp

270 °C (lit.)

antibiotic activity spectrum

neoplastics

mode of action

DNA synthesis | interferes

Quality Level

100

正在寻找类似产品? 访问 产品对比指南

相关类别

Application

顺二氯化二胺（II）可用作模型药物以测试药物递送中各种药物载体的效率。
高活性化疗剂，可用于预防睾丸癌的进展。

Biochem/physiol Actions

强效的铂基抗肿瘤剂。与 DNA 二核苷酸 d(pGpG) 形成细胞毒性加合物，诱导链内交联。

pictograms

Skull and crossbonesHealth hazard
GHS06,GHS08

signalword

Danger

Hazard Classifications

Acute Tox. 2 Oral - Carc. 1B - Eye Irrit. 2 - Resp. Sens. 1 - Skin Irrit. 2 - Skin Sens. 1 - STOT SE 3

target_organs

Respiratory system

存储类别

6.1A - Combustible acute toxic Cat. 1 and 2 / very toxic hazardous materials

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Faceshields, Gloves, type P3 (EN 143) respirator cartridges

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number
MKCZ9966
MKCZ2360
MKCX3349
MKCV6980
MKCX0285

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

  1. Which document(s) contains shelf-life or expiration date information for a given product?

    If available for a given product, the recommended re-test date or the expiration date can be found on the Certificate of Analysis.

  2. How do I get lot-specific information or a Certificate of Analysis?

    The lot specific COA document can be found by entering the lot number above under the "Documents" section.

  3. How can I get Product 479306, cis-Diammineplatinum(II) dichloride, in solution?

    cis-Diammineplatinum(II) dichloride is soluble in water at 25°C. It is also soluble in N,N-dimethylformamide (DMF), dimethylacetamide and dimethyl sulfoxide (DMSO). We do not test solution stability of this product. However, we do have stability data on a document on another cis-Diammineplatinum(II) dichloride product; the product number is P4394.

  4. How should Product 479306, cis-Diammineplatinum(II) dichloride be stored?

    This product should be stored at room temperature.

  5. How do I find price and availability?

    There are several ways to find pricing and availability for our products. Once you log onto our website, you will find the price and availability displayed on the product detail page. You can contact any of our Customer Sales and Service offices to receive a quote.  USA customers:  1-800-325-3010 or view local office numbers.

  6. What is the Department of Transportation shipping information for this product?

    Transportation information can be found in Section 14 of the product's (M)SDS.To access the shipping information for this material, use the link on the product detail page for the product. 

  7. My question is not addressed here, how can I contact Technical Service for assistance?

    Ask a Scientist here.

Highly stable core-surface-crosslinked nanoparticles as cisplatin carriers for cancer chemotherapy.
Xu P, et al.
Colloids and Surfaces. B, Biointerfaces, 48(1), 50-57 (2006)
Synthesis of a new nanoparticle system based on electrostatic alginate?piperazine interactions.
Roman JV, et al.
Polymers For Advanced Technologies, 27(5), 623-629 (2016)
Koji Tanaka et al.
Carcinogenesis, 36(8), 894-903 (2015-05-31)
There is increasing evidence that the expression of microRNA (miRNA) in cancer is associated with chemosensitivity but the mechanism of miRNA-induced chemoresistance has not been fully elucidated. The aim of this study was to examine the role of extracellular miRNA
Pedro J Beltran et al.
Clinical cancer research : an official journal of the American Association for Cancer Research, 20(11), 2947-2958 (2014-04-15)
Insulin-like growth factor 1 receptor (IGF-IR) has been implicated in the pathogenesis of ovarian cancer. Ganitumab is an investigational, fully human monoclonal antibody against IGF-IR. Here, we explore the therapeutic potential of ganitumab for the treatment of ovarian cancer. The
Abdullah A Osman et al.
Cancer research, 75(7), 1205-1215 (2015-02-19)
TP53 is the most frequently altered gene in head and neck squamous cell carcinoma (HNSCC), with mutations occurring in over two thirds of cases; however, the predictive response of these mutations to cisplatin-based therapy remains elusive. In the current study
查看所有相关文献

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持